10 Micro-, Small-Cap Firms Dominate Thursday’s Gains

7. Nanovibronix Inc. (NASDAQ:NAOV)

Nanovibronix rose for a second day on Thursday, jumping 36.5 percent to close at $4.45 each as investor confidence was fueled by the efficacy of its UroShield device in preventing catheter-associated urinary tract infections (UTI).

According to NAOV, the study found that UroShield reduced UTI by 86 percent, catheter blockages by 70 percent, and bladder irrigations by 82.8 percent.

Clinicians have also reported lower intervention needs and nursing time.

NAOV is a medical device company headquartered in Tyler, Texas, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low-intensity surface acoustic wave (SAW) technology.

The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the continuous assistance of medical professionals.